05486nam 22009735 450 991038074200332120230822223102.03-030-35918-210.1007/978-3-030-35918-8(CKB)4100000010480423(DE-He213)978-3-030-35918-8(MiAaPQ)EBC6122108(Au-PeEL)EBL6122108(OCoLC)1143625864(oapen)https://directory.doabooks.org/handle/20.500.12854/31058(PPN)24298164X(EXLCZ)99410000001048042320200219d2020 u| 0engurnn#008mamaatxtrdacontentcrdamediacrrdacarrierAdvances in Pharma Business Management and Research[electronic resource] Volume 1 /edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen1st ed. 2020.Springer Nature2020Cham :Springer International Publishing :Imprint: Springer,2020.1 online resource (X, 85 p. 11 illus.)3-030-35917-4 Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.Pharmaceutical technologyHealth care managementHealth services administrationMedical laws and legislationPharmacyPharmacy managementPharmaceutical Sciences/Technologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B21010Health Care Managementhttps://scigraph.springernature.com/ontologies/product-market-codes/527030Medical Lawhttps://scigraph.springernature.com/ontologies/product-market-codes/R16005Pharmacyhttps://scigraph.springernature.com/ontologies/product-market-codes/F00008Pharmacoeconomics and Health Outcomeshttps://scigraph.springernature.com/ontologies/product-market-codes/H69020Pharmaceutical Sciences/TechnologyHealth Care ManagementMedical LawPharmacyPharmacoeconomics and Health OutcomesPharmaceuticsHealth CarePharmacologyPharma ManagementMarket AccessRegulatory AffairsResearch & DevelopmentQuality ControlOpen AccessIndustrial chemistry & chemical engineeringHealth economicsMedical & healthcare lawPharmacy / dispensingPharmaceutical technology.Health care management.Health services administration.Medical laws and legislation.Pharmacy.Pharmacy management.Pharmaceutical Sciences/Technology.Health Care Management.Medical Law.Pharmacy.Pharmacoeconomics and Health Outcomes.615.19Schweizer Larsedt1356483Schweizer Larsedthttp://id.loc.gov/vocabulary/relators/edtDingermann Theodoredthttp://id.loc.gov/vocabulary/relators/edtRusse Otto Quintusedthttp://id.loc.gov/vocabulary/relators/edtJansen Christianedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910380742003321Advances in Pharma Business Management and Research3361062UNINA